Description References
ChemicalBook > CAS DataBase List > Lornoxicam

Lornoxicam

Description References
Product Name
Lornoxicam
CAS No.
70374-39-9
Chemical Name
Lornoxicam
Synonyms
Lornoxicam Impurity 33;6-Chloro-4-hydroxy-2-methyl-N-pyridin-2-yl-2H-thieno[2,3-e][1,2]thiazine-3-carboxamide 1,1-dioxide (Lornoxicam);Xefo;Telos;TS 110;Xefocam;ornoxicam;AKOS 93662;LORNOXICAM;Ro 13-9297
CBNumber
CB7224647
Molecular Formula
C13H10ClN3O4S2
Formula Weight
371.82
MOL File
70374-39-9.mol
More
Less

Lornoxicam Property

Melting point:
225-230°C (dec.)
Density 
1.742±0.06 g/cm3(Predicted)
storage temp. 
Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
solubility 
DMSO: >5mg/mL (warmed)
pka
pKa2 4.7(at 25℃)
form 
powder
color 
faint yellow to dark yellow
Merck 
14,5582
InChI
InChI=1S/C13H10ClN3O4S2/c1-17-10(13(19)16-9-4-2-3-5-15-9)11(18)12-7(23(17,20)21)6-8(14)22-12/h2-6,18H,1H3,(H,15,16,19)
InChIKey
WLHQHAUOOXYABV-UHFFFAOYSA-N
SMILES
S1(=O)(=O)C2C=C(Cl)SC=2C(O)=C(C(NC2=NC=CC=C2)=O)N1C
CAS DataBase Reference
70374-39-9(CAS DataBase Reference)
More
Less

Safety

Hazard Codes 
Xi,T+
Risk Statements 
36/37/38-28
Safety Statements 
26-36-45-36/37-28
RIDADR 
UN 2811 6.1 / PGII
WGK Germany 
3
RTECS 
XJ9095000
HazardClass 
IRRITANT
PackingGroup 
II
HS Code 
29349990
Toxicity
LD50 orally in mice, rats, rabbits, dogs, monkeys: >10 mg/kg (Pruss)
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Danger
Hazard statements

H300Fatal if swallowed

Precautionary statements

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P301+P310IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
SML0338
Product name
Lornoxicam
Purity
≥98% (HPLC)
Packaging
10mg
Price
$96.7
Updated
2024/03/01
Sigma-Aldrich
Product number
SML0338
Product name
Lornoxicam
Purity
≥98% (HPLC)
Packaging
50mg
Price
$314
Updated
2024/03/01
TCI Chemical
Product number
L0239
Product name
Lornoxicam
Purity
>98.0%(HPLC)(N)
Packaging
1g
Price
$135
Updated
2024/03/01
TCI Chemical
Product number
L0239
Product name
Lornoxicam
Purity
>98.0%(HPLC)(N)
Packaging
5g
Price
$404
Updated
2024/03/01
Cayman Chemical
Product number
70220
Product name
Lornoxicam
Purity
≥98%
Packaging
50mg
Price
$57
Updated
2024/03/01
More
Less

Lornoxicam Chemical Properties,Usage,Production

Description

Lornoxicam (Trade name: “Xefo”) belongs to a non-steroidal anti-inflammatory drug. As a kind of oxicam class drug, it has analgesic, anti-inflammatory and antipyretic properties. It can be used for the treatment of various type of acute mild to moderate pain which results from inflammatory diseases of the joints, osteoarthritis, surgery, sciatica and rheumatic diseases. Lornoxicam is capable of potently inhibiting the prostaglandin biosynthesis process, making it have highly pronounced efficacy. The exact mechanism of Lornoxicam is not exactly understood. However, it is indicated that Lornoxicam can inhibit the prostaglandin and thromboxane synthesis by inhibiting both COX-1 and COX-2, leading to reduction of inflammation, pain, fever, and swelling.

References

https://www.drugbank.ca/drugs/DB06725
https://en.wikipedia.org/wiki/Lornoxicam

Description

Lornoxicam is a COX inhibitor and non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory and analgesic properties. It inhibits production of thromboxane B2 (TXB2; ) from arachidonic acid (Item Nos. 90010 | 90010.1 | 10006607) in HEL human erythroleukemic cells (IC50 = 3 nM), which endogenously express COX-1, as well as inhibits LPS-induced formation of prostaglandin F1α (PGF1α; ) from arachidonic acid in Mono-Mac-6 cells (IC50 = 8 nM), which endogenously express COX-2. Lornoxicam reduces LPS-induced production of nitric oxide and IL-6 in cell-based assays with IC50 values of 65 and 54 μM, respectively. It reduces carrageenan-induced paw edema in rats when administered intravenously at doses ranging from 0.1 to 9 mg/kg. Formulations containing lornoxicam have been used in the management of postoperative pain.

Description

Lornoxicam is a nonselective NSAID for oral and intravenous administration. It has been available for human use since two decades and there is a growing body of evidence supporting its efficacy and tolerability for management of acute pain.
Xefo, a member of the oxicam family of nonsteroidal antiinflammatory agents, was launched in Denmark for mild to moderate pain and inflammation. A seven step synthesis, beginning with 2,5-dichlorothiophene, provides access to this compound. It inhibits prostaglandin synthesis at the level of cyclooxygenase (Cox1 :Cox2 = 0.6) but does not inhibit 5-lipoxygenase. Xefo did not increase serum levels of pepsinogen I (an indicator of gastric mucosal status) and readily penetrates perivascular interstitial spaces including synovial fluid. It is as effective as morphine, meperidine and tramadol in relieving post operative pain and as efficient as other NSAlDs in relieving the symptoms of osteoarthritis and rheumatoid arthritis. It is 100 times more potent than Tenoxicam in inhibiting PGD2 and more active than indomethacin (6x) or piroxicam (10x) in preventing arachadonic acid influenced lethality in mice. Xefo has inhibitor effects on spinal nocicceptive processing presumably via release of endogenous opiods and evidence suggests it is good for migraine.

Chemical Properties

Crystalline Solid

Originator

Nycomed Amersham (Norway)

Uses

keratolytic, antiacne, antineoplastic

Uses

Lornoxicam belongs to the oxicam class. It has anti-inflammatory and antipyretic properties. Lornoxicam prevents the synthesis of prostaglandin (PG) by inhibiting cyclo-oxygenase. It is used to relieve various types of symptoms associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute sciatica and low back pain.Lornoxicam is approved for use in Japan.
Lornoxicam has been used as a drug in melanin binding study with cassette dosing and rapid equilibrium dialysis inserts. Lornoxicam differs from other oxicam compounds in its potent inhibition of prostaglandin biosynthesis, a property that explains the particularly pronounced efficacy of the drug.

Uses

For the treatment of acute mild to moderate pain, as well as pain and inflammation of the joints caused by certain types of rheumatic diseases.

Uses

Cyclooxygenase inhibitor; structurally similar to tenoxicam. Anti-inflammatory; analgesic

Definition

ChEBI: A thienothiazine-derived monocarboxylic acid amide obtained by formal condensation of the carboxy group of 6-chloro-4-hydroxy-2-methylthieno[2,3-e][1,2]thiazine-3-carboxylic acid 1,1-dioxide with the amino group of 2-aminopyridine. Used for th treatment of pain, primarily resulting from inflammatory diseases of the joints, osteoarthritis, surgery, sciatica and other inflammations.

Indications

Lornoxicam is a non-steroidal anti-inflammatory drug (NSAID) that is used as a painkiller (analgesic). A high level of pain relief is experienced by about 45% of those with moderate to severe postoperative dental pain after a single dose of lornoxicam 8 mg, compared to about 10% with placebo. This is comparable to the proportion experiencing the same level of pain relief with ibuprofen 200 to 400 mg. Adverse events were generally mild and did not differ from placebo in these singe dose studies. There were insufficient data to assess duration of action, but it is likely to be similar to ibuprofen 200 mg.

brand name

Xefo

in vitro

studies on intact human cells showed that lornoxicam intensively inhibit cox-1 and cox-2 with the lowest ic50 among a large panel of nsaids tested. similar findings were obtained in the whole blood for cox-1/-2. in addition lornoxicam suppressed no formation in a dose-dependently manner with an ic50 of 65 μm. [2]

in vivo

in vivo studies found that lornoxicam was as effective as comparative nsaids and that 8 mg lornoxicam was more effective than 10 mg morphine as a pain-reliever after oral surgery. orally administration of lornoxicam at 16-24 mg daily was more effective than tramadol at 300 mg daily in pain-alleviating after knee surgery. compared to naproxen, lornoxicam showed higher therapeutic potency and lower gastrointestinal toxicity. this was probably due to the short half-life of lornoxicam as compared to the other oxicams. [3]

IC 50

a potent cox-1 and cox-2 inhibitor with ic50 values of 5 nm and 8 nm, respectively.

References

[1]balfour ja, fitton a and barradell lb. lornoxicam, a review of its pharmacology and therapeutic potential in the management of painful and inflammatory conditions. drugs. 1996 apr; 51(4): 639-57.
[2]berg j, fellier h, christoph t, grarup j and stimmeder d. the analgesic nsaid lornoxicam inhibits cyclooxygenase (cox)-1/-2, inducible nitric oxide synthase (inos), and the formation of interleukin (il)-6 in vitro. inflamm res. 1999 jul; 48(7): 369-79.
[3]radhofer-welte s and rabasseda x. lornoxicam, a new potent nsaid with an improved tolerability profile. drugs today (barc). 2000 jan; 36(1): 55-76.
[4]sharma a, pingle a, and baliga vp. lornoxicam efficacy in acute pain (leap) trial. j indian med assoc. 2008 dec; 106(12): 811-3.

Lornoxicam Preparation Products And Raw materials

Raw materials

Sodium hydride 2,5-Dichlorothiophene Iodoacetic acid thiazine Chlorosulfonic acid Phosphorus pentachloride 2-Aminopyridine Methyl acetate n-Butyllithium

Preparation Products

More
Less

Lornoxicam Suppliers

Americas 1 Austria 1 Belgium 1 Canada 3 China 377 Europe 3 France 2 Germany 4 Greece 1 India 107 Japan 4 Nepal 1 Sweden 1 Switzerland 1 The Netherlands 1 United Kingdom 17 United States 46 Global 571
Jai Radhe Sales
Tel
+(91)-(79)-26431096/65255722
Fax
+(91)-(79)-26569884
Email
info@jairadhesales.com
Country
India
ProdList
397
Advantage
60
TCI Chemicals (India) Pvt. Ltd.
Tel
--
Fax
--
Email
sales-in@tcichemicals.com
Country
India
ProdList
6768
Advantage
58
Jigs chemical
Tel
--
Fax
--
Email
info@jigschemical.com
Country
India
ProdList
318
Advantage
58
Jigs Chemical Limited
Tel
--
Fax
--
Email
info@jigschemical.com
Country
India
ProdList
235
Advantage
58
Abil Chempharma Private Limited
Tel
--
Fax
--
Country
India
ProdList
22
Advantage
58
Anant Pharmaceuticals Pvt. ltd
Tel
--
Fax
--
Email
info@anantlabs.com
Country
India
ProdList
736
Advantage
58
Yaksh Pharma
Tel
--
Fax
--
Email
info@yaksh-pharma.com
Country
India
ProdList
15
Advantage
58
Sai Prathyu Marketing
Tel
--
Fax
--
Country
India
ProdList
162
Advantage
58
Afton Pharma
Tel
--
Fax
--
Email
info@aftonpharma.com
Country
India
ProdList
40
Advantage
58
Novas International
Tel
--
Fax
--
Email
info@novasinternational.com
Country
India
ProdList
210
Advantage
58
Progress Life Sciences Pvt. Ltd.
Tel
--
Fax
--
Email
info@progresslifesciences.com
Country
India
ProdList
25
Advantage
58
ASolution Pharmaceuticals Pvt. Ltd.
Tel
--
Fax
--
Country
India
ProdList
9
Advantage
58
Orient Pharma
Tel
--
Fax
--
Email
info@orientpharma.in
Country
India
ProdList
204
Advantage
58
Pharma Links
Tel
--
Fax
--
Email
info@pharmalinksindia.com
Country
India
ProdList
85
Advantage
58
Vyshno Bio Sciences
Tel
--
Fax
--
Email
info@vyshnobio.com
Country
India
ProdList
239
Advantage
58
Imex Overseas
Tel
--
Fax
--
Email
info@imexoverseas.in
Country
India
ProdList
45
Advantage
58
Euro-India Chems Pvt., Ltd.
Tel
--
Fax
--
Email
euroindiachems@gmail.com
Country
India
ProdList
31
Advantage
58
Hetero Drugs Limited
Tel
--
Fax
--
Country
India
ProdList
174
Advantage
58
Gemini Exports
Tel
--
Fax
--
Email
uiry@geminiexpor
Country
India
ProdList
140
Advantage
58
Pure Chem Pvt. Ltd.
Tel
--
Fax
--
Email
info@purechemindia.com
Country
India
ProdList
6
Advantage
58
Viraj Pharmaceuticals Pvt. Ltd.
Tel
--
Fax
--
Email
virajppl@gmail.com
Country
India
ProdList
162
Advantage
58
Aadivighnesh Chem Private Ltd.
Tel
--
Fax
--
Email
sales@aadivighnesh.com
Country
India
ProdList
119
Advantage
58
Athos Chemicals
Tel
--
Fax
--
Email
export@athoschemicals.com
Country
India
ProdList
315
Advantage
58
Harsh Pharmachem
Tel
--
Fax
--
Email
harshpharmachem@gmail.com
Country
India
ProdList
39
Advantage
58
Radhashok Pharmachem Pvt., Ltd.
Tel
--
Fax
--
Email
priyanka@radhashok.com
Country
India
ProdList
30
Advantage
58
Prayosha Health Care Pvt. Ltd.
Tel
--
Fax
--
Email
prayosha_6209@yahoo.com
Country
India
ProdList
11
Advantage
58
Manus Aktteva Biopharma LLP
Tel
--
Fax
--
Country
India
ProdList
655
Advantage
58
Sibram Pharmaceutical
Tel
--
Fax
--
Email
contact@sibram.com
Country
India
ProdList
136
Advantage
58
Dazzle Corporation
Tel
--
Fax
--
Email
enquiry@dazzlecorporation.co.in
Country
India
ProdList
209
Advantage
58
Disha APIs Pvt Ltd
Tel
--
Fax
--
Email
info@dishaapis.com
Country
India
ProdList
90
Advantage
58
Ayon PharmaChem
Tel
--
Fax
--
Email
bhargav@ayonpharmachem.com
Country
India
ProdList
303
Advantage
58
Salavidas Pharmaceutical Pvt., Ltd.
Tel
--
Fax
--
Email
inquiry@salvavidaspharma.com
Country
India
ProdList
72
Advantage
58
Unnati Pharmaceuticals Pvt. Ltd.
Tel
--
Fax
--
Email
unnatipharma@gmail.com
Country
India
ProdList
86
Advantage
58
Goalsy Laboratories
Tel
--
Fax
--
Email
info@goalsylaboratories.com
Country
India
ProdList
42
Advantage
58
Standhardt Innovations.
Tel
--
Fax
--
Email
info@standhardtinnovations.com
Country
India
ProdList
5
Advantage
58
CAD Pharma Inc.
Tel
--
Fax
--
Email
contact@cadpharma.com
Country
India
ProdList
123
Advantage
58
Medica Pharma Chem
Tel
--
Fax
--
Country
India
ProdList
15
Advantage
58
Kkyemistry (india) Pvt., Ltd.
Tel
--
Fax
--
Email
marketing@kyemistryindia.com
Country
India
ProdList
163
Advantage
58
International Drug & Chemical Co.
Tel
--
Fax
--
Email
sales@idcco.com
Country
India
ProdList
65
Advantage
58
BDR Pharmaceuticals International Pvt., Ltd.
Tel
--
Fax
--
Email
marketing@bdrpharma.com
Country
India
ProdList
91
Advantage
58
Dharmanandan Export Pvt., Ltd.
Tel
--
Fax
--
Email
info@dnexport.com
Country
India
ProdList
161
Advantage
58
Clearsynth Labs
Tel
--
Fax
--
Email
fo@clearsynth.com
Country
India
ProdList
3887
Advantage
58
ALEX INDUSTRIES
Tel
--
Fax
--
Country
India
ProdList
13
Advantage
58
B. Shah & Sons
Tel
--
Fax
--
Country
India
ProdList
79
Advantage
58
Avience chemicals and pharmaceuticals
Tel
--
Fax
--
Email
expoavience@gmail.com
Country
India
ProdList
180
Advantage
58
Akhil Healthcare Pvt., Ltd.
Tel
--
Fax
--
Email
info@akhilhealthcare.com
Country
India
ProdList
71
Advantage
58
Pharmaffiliates Analytics & Synthetics (P) Ltd.
Tel
--
Fax
--
Email
g@pharmaffiliates.com
Country
India
ProdList
631
Advantage
58
Heer Pharma Pvt., Ltd.
Tel
--
Fax
--
Email
marketing@heerpharma.com
Country
India
ProdList
31
Advantage
58
Paradise Healthcare
Tel
--
Fax
--
Country
India
ProdList
7
Advantage
58
Global Chem Asia Pacific
Tel
--
Fax
--
Email
ghu@globalchem.in
Country
India
ProdList
255
Advantage
58
More
Less

View Lastest Price from Lornoxicam manufacturers

HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
Product
Lornoxicam 70374-39-9
Price
US $999.00-666.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
5000
Release date
2024-08-09
WUHAN FORTUNA CHEMICAL CO., LTD
Product
Lornoxicam 70374-39-9
Price
US $0.00/Kg/Bag
Min. Order
1KG
Purity
98%min
Supply Ability
25kg
Release date
2021-10-19
HebeiShuoshengImportandExportco.,Ltd
Product
Lornoxicam 70374-39-9
Price
US $6.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
2000KG/Month
Release date
2024-08-02

70374-39-9, LornoxicamRelated Search:

4-Dimethylaminopyridine Basic Violet 1 4,5,6,7-Tetrahydrothieno[3,2-c]pyridine 2-Hydroxypyridine 3-Aminopyridine Methyl salicylate CHLOROPHOSPHONAZO III Tribenuron methyl Kresoxim-methyl Methylparaben Methanol 2-Aminopyridine Methyl acrylate 5-HYDROXY LORNOXICAM Methyl 6-Chloro-4-hydroxy-2-methyl-2H-thieno[2,3-e]-1,2-thiazine-3-carboxylic acid methyl ester 1,1-dioxide (Lornoxicam),LORNOXICAM INTERMEDIATE 5-Chloro-3-(N-methylsulfamoyl)-thiophene-2-carboxylic acid methyl ester (Lornoxicam) 5-Chloro-3-[N-(methoxy-carbonyl-methyl)sulfamoyl]-2-thiophene carboxylic acid methyl ester (Lornoxicam)

  • LORNOXICAM
  • AKOS 93662
  • 6-Chloro-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno[2,3-e][1,2]thiazine-3-carboxamide 1,1-dioxide
  • LornoxicaM for injection
  • 6-Chloro-4-hydroxy-2-Methyl-N-2-pyridinyl-
  • LornoxicaM API
  • 6-Chloro-4-hydroxy-2-Methyl-N-pyridin-2-yl-2H-thieno[2,3-e][1,2]thiazine-3-carboxaMide
  • LornoxicaM (Xefo)
  • 6-Chloro-4-hydroxy-2-methyl-N-pyridin-2-yl-2H-thie no[2,3-e][1,2]thiazine-3-carboxamide 1,1-dioxi
  • 1,1-dioxide-6-chloro-4-hydroxy-2-methyl-N-2-pyridinyl-2H-thieno[2,3-e]-1,2-thiazine-3-carboxamide
  • 6-Chloro-4-hydroxy-2-methyl-N-pyridin-2-yl-2H-thieno[2,3-e][1,2]thiazine-3-carboxamide 1,1-dio
  • Lornoxicam, 98%, a non-steroidal COX-1/COX-2 inhibitor
  • 6-CHLORO-4-HYDROXY-2-METHYL-N-2-PYRIDINYL-2H-THIENO[2,3-E]-1,2-THIAZINE-3-CARBOXAMIDE 1,1-DIOXIDE
  • 2h-thieno(2,3-e)-1,2-thiazine-3-carboxamide,6-chloro-4-hydroxy-2-methyl-n-2-py
  • chlortenoxicam
  • ridinyl-,1,1-dioxide
  • 6-Chloro-4-hydroxy-2-methyl-N-pyridin-2-yl-2H-thieno[2,3-e][1,2]thiazine-3-carboxamide-1,1-dioxide
  • LornoxicamConsultedStandard
  • Ro 13-9297
  • Telos
  • TS 110
  • Xefo
  • Xefocam
  • 6-Chloro-4-hydroxy-2-methyl-N-pyridin-2-yl-2H-thieno[2,3-e][1,2]thiazine-3-carboxamide 1,1-dioxide (Lornoxicam)
  • 6-Chloro-4-hydroxy-2-methyl-N-2-pyridinyl-2H-thieno[2,3-e]-1，2-thiazine-3-carboxamidel，1-dioxide
  • (3Z)-6-chloro-3-[hydroxy-(2-pyridinylamino)methylidene]-2-methyl-1,1-dioxo-4-thieno[2,3-e]thiazinone
  • Lornoxicam&gt
  • ornoxicam
  • 6-chloro-4-hydroxy-2-methyl-1,1-dioxo-N-(pyridin-2-yl)-2H-1$l^{6},5,2-thieno[2,3-e][1$l^{6},2]thiazine-3-carboxamide
  • 2H-Thieno[2,3-e]-1,2-thiazine-3-carboxamide, 6-chloro-4-hydroxy-2-methyl-N-2-pyridinyl-, 1,1-dioxide
  • Lornoxicam USP/EP/BP
  • Lornoxicam Impurity 33
  • Lornoxicam (Chlortenoxicam
  • LornoxicamQ: What is Lornoxicam Q: What is the CAS Number of Lornoxicam Q: What is the storage condition of Lornoxicam Q: What are the applications of Lornoxicam
  • Yesterday, the chlorine
  • methyl 5-chloro-3-(ethoxysulfonyl)thiophene-2-carboxylate
  • Lornoxicam INH
  • Lornoxicam, ≥ 98.0%
  • Ro 13-9297|||Chlortenoxicam|||TS110
  • 70374-39-9
  • 原料药 > 解热镇痛药 > 非甾抗炎药 > 氯诺昔康
  • C13H10ClN3O4S2
  • AVITA
  • Other APIs
  • API
  • Fused Ring Systems
  • APIs
  • Inhibitors
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
  • Sulfur & Selenium Compounds
  • 70374-39-9